CenterWatch

Clinical Trial Details

Overview

Research Study Summary

COPD Chronic

Purpose

Purpose:

This study evaluates the long-term safety of Roflumilast in patients with chronic COPD. The medication is already available and on the market today.

Duration:

52 Weeks

Visits:

9 Visits

Compensation:

$100 per visit for visits 1-8 and $50 for visit 9 and $15 for unscheduled visits. You may be reimbursed up to $25

Criteria:

Males and Females over the age 40 with a diagnosis of moderate or severe COPD. Other criteria may apply.

To Learn more

CW ID: 183341
Date Last Changed: July 16, 2013

Clinical Trial Snapshot

Gender
Both Male and Female
Age
40 and up
Overall Status
Recruiting
Duration
52 Weeks
Facility Type
N/A
Compensation
$100 to $850

Contact

Kentucky Medical Research
354 Waller Avenue, Suite 110
Lexington, KY 40504
Phone: 859-225-5672
Fax: 859-276-1020

View Map

Research Center Information: Kentucky Medical Research

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.